IL6 and cancer: Recent reports highlight the involvement of IL-6 family cytokine signaling and chronic inflammation in resistance to immune checkpoint inhibition-based therapies.52,63 However, the implications of OSM-OSMR signaling in cancer immunotherapy remain relatively unexplored.